Jill D. Martin

Array ( [id] => 1550879 [patent_doc_number] => 06399585 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'In Utero treatment of CFTR-related deficiencies' [patent_app_type] => B1 [patent_app_number] => 09/065380 [patent_app_country] => US [patent_app_date] => 1998-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 55 [patent_no_of_words] => 33179 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399585.pdf [firstpage_image] =>[orig_patent_app_number] => 09065380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359085 [patent_doc_number] => 06218597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Transgenic model and treatment for heart disease' [patent_app_type] => 1 [patent_app_number] => 9/053293 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 7011 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218597.pdf [firstpage_image] =>[orig_patent_app_number] => 053293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944861 [patent_doc_number] => 05981830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Knockout mice and their progeny with a disrupted hepsin gene' [patent_app_type] => 1 [patent_app_number] => 9/000846 [patent_app_country] => US [patent_app_date] => 1997-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14042 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981830.pdf [firstpage_image] =>[orig_patent_app_number] => 000846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072640 [patent_doc_number] => 05965441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'HSV/AAV hybrid amplicon vectors' [patent_app_type] => 1 [patent_app_number] => 8/968434 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12739 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965441.pdf [firstpage_image] =>[orig_patent_app_number] => 968434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4202290 [patent_doc_number] => 06013858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Mouse lacking heart-muscle adenine nucleotide translocator protein and methods' [patent_app_type] => 1 [patent_app_number] => 8/961871 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 14 [patent_no_of_words] => 11816 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013858.pdf [firstpage_image] =>[orig_patent_app_number] => 961871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220460 [patent_doc_number] => 06087555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Mice lacking expression of osteoprotegerin' [patent_app_type] => 1 [patent_app_number] => 8/943687 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 7753 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087555.pdf [firstpage_image] =>[orig_patent_app_number] => 943687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4159330 [patent_doc_number] => 06107540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Mice models of human prostate cancer progression' [patent_app_type] => 1 [patent_app_number] => 8/951143 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 14948 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107540.pdf [firstpage_image] =>[orig_patent_app_number] => 951143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409192 [patent_doc_number] => 06271436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Cells and methods for the generation of transgenic pigs' [patent_app_type] => 1 [patent_app_number] => 8/949155 [patent_app_country] => US [patent_app_date] => 1997-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 83962 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271436.pdf [firstpage_image] =>[orig_patent_app_number] => 949155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979160 [patent_doc_number] => 05917124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Transgenic mouse model of prostate cancer' [patent_app_type] => 1 [patent_app_number] => 8/927986 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10752 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/917/05917124.pdf [firstpage_image] =>[orig_patent_app_number] => 927986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305360 [patent_doc_number] => 06251957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Method of reducing an immune response to a recombinant virus' [patent_app_type] => 1 [patent_app_number] => 8/894488 [patent_app_country] => US [patent_app_date] => 1997-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 13936 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251957.pdf [firstpage_image] =>[orig_patent_app_number] => 894488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4189701 [patent_doc_number] => 06093873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Genetically engineered mice containing alterations in the gene encoding RXR' [patent_app_type] => 1 [patent_app_number] => 8/914256 [patent_app_country] => US [patent_app_date] => 1997-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 9490 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093873.pdf [firstpage_image] =>[orig_patent_app_number] => 914256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260691 [patent_doc_number] => 06258787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Treatment of vascular injury' [patent_app_type] => 1 [patent_app_number] => 8/910539 [patent_app_country] => US [patent_app_date] => 1997-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 9712 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258787.pdf [firstpage_image] =>[orig_patent_app_number] => 910539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4130751 [patent_doc_number] => 06127598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'NKX-2.2 and NKX-6.1 transgenic mouse models for diabetes, depression, and obesity' [patent_app_type] => 1 [patent_app_number] => 8/900510 [patent_app_country] => US [patent_app_date] => 1997-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16788 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127598.pdf [firstpage_image] =>[orig_patent_app_number] => 900510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596509 [patent_doc_number] => 06384298 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Transgenic mice depleted in a mature lymphocytic cell-type' [patent_app_type] => B1 [patent_app_number] => 08/899708 [patent_app_country] => US [patent_app_date] => 1997-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 14734 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384298.pdf [firstpage_image] =>[orig_patent_app_number] => 08899708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4000746 [patent_doc_number] => 05922927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods for producing tetracycline-regulated transgenic mice' [patent_app_type] => 1 [patent_app_number] => 8/897719 [patent_app_country] => US [patent_app_date] => 1997-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 3 [patent_no_of_words] => 27029 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922927.pdf [firstpage_image] =>[orig_patent_app_number] => 897719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944845 [patent_doc_number] => 05981829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => '.DELTA.Nur77 transgenic mouse' [patent_app_type] => 1 [patent_app_number] => 8/852173 [patent_app_country] => US [patent_app_date] => 1997-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 8 [patent_no_of_words] => 10817 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981829.pdf [firstpage_image] =>[orig_patent_app_number] => 852173 [rel_patent_id] =>[rel_patent_doc_number] =>)